Ying Fei Li

Ying Fei is Director of Pharmacometrics at Novartis, where she leads the application of model-informed approaches to support drug development and strategic decision-making across the portfolio. With more than a decade of experience spanning pharmacometrics, clinical pharmacology, translational modelling, and biologics development, she has held scientific leadership roles at Novartis, Celgene, and Merck, leveraging quantitative sciences to inform study design, dose selection, and development strategy from early research through clinical development.